Practical recommendations to prevent reoccurrence are made through a widely distributed newsletter and other educational efforts.The information derived from the programme has also allowed us to influence the pharmaceutical industry, device manufacturers, and regulatory bodies such as the Food and Drug Administration to change healthcare standards and medical product design.